EODData

LSE, 0Q77: Ab Science Ord Shs

24 Mar 2026
LAST:

1.180

CHANGE:
 0.04
OPEN:
1.226
HIGH:
1.226
ASK:
0.000
VOLUME:
4.0K
CHG(%):
3.28
PREV:
1.220
LOW:
1.180
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Mar 261.2261.2261.1801.1804.0K
23 Mar 261.2001.2201.1841.220100
20 Mar 261.2321.2321.2321.2327
19 Mar 261.2321.2321.2321.232100
18 Mar 261.2421.2421.2421.242100
17 Mar 261.2201.2441.2201.244353
16 Mar 261.2201.2441.2201.244351
13 Mar 261.2401.2401.2401.2400
12 Mar 261.2741.2741.2741.27412
11 Mar 261.2741.2741.2741.27412

PROFILE

Name:Ab Science Ord Shs
About:AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company's lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer's disease, and indolent systemic mastocytosis, as well as in Phase 2 trial for mast cell activation syndrome and sickle cell disease. It also develops AB8939, a microtubule destabilizer in Phase 1 trial for the treatment of acute myeloid leukemia; and AB12319 in preclinical trial to treat sarcoma and solid tumors. In addition, the company markets its masitinib under the Masivet brand for the treatment of mast cell tumors in dogs in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Address:3, Avenue George V, Paris, France, 75008
Website:https://www.ab-science.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-128.40 
Price to Sales:50.69 
Price to Book:-3.43 
Operating Margin:-5.30 
Return on Assets:-0.15 
Return on Equity:-0.07 
EPS Ratio:-0.30 
Revenue:1.03M 
Shares:41.06M 
Market Cap:48.46M 

TECHNICAL INDICATORS

MA5:1.223.5%
MA10:1.244.9%
MA20:1.278.0%
MA50:1.3313.0%
MA100:1.299.7%
MA200:1.3010.2%
RSI14:3.08 
WPR14:-100.00 
MTM14:-0.12
ROC14:-0.09 
ATR:0.02 
Week High:1.245.4%
Week Low:1.180.0%
Month High:1.3917.9%
Month Low:1.1810.2%
Year High:1.7245.6%
Year Low:0.9721.6%
Volatility:35.83